Regulations.gov document
Statement of Identity and Strength — Content and Format of Labeling for Human…
Other · FDA-2022-D-1837 · posted Sep 9, 2022
Key facts
| Document ID | FDA-2022-D-1837-0002 |
|---|---|
| Title | Statement of Identity and Strength — Content and Format of Labeling for Human Nonprescription Drug Products; Guidance for Industry; DRAFT GUIDANCE |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2022-D-1837 |
| Posted | Sep 9, 2022 |
| Comment period opens | Sep 9, 2022 |
| Comments due | Nov 9, 2022 |
At a glance
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: